Searched for
NEVIRAPINE
Cipla is undergoing a big transformation and is doing something it once eschewedA difficult transformation is underway at Cipla, one of India’s largest and oldest pharma companies.- Sensex jumps 150 pts, Nifty50 reclaims 10,900; Tata Motors, Bharti Airtel lead gainsThe BSE Sensex climbed over 150 points, before paring some gains.
- Stocks in the news: Jet Airways, Infibeam, Cipla and Fortis HealthcareHere are a few stocks whuich may buzz the most in today's trade.
- What changed your markets while you were sleepingActivity in China’s manufacturing sector contracted in December for the first time in more than two years.
- Cipla recalls 4,800 bottles of anti-HIV tablets from USAs per the latest Enforcement Report by the United States Food and Drug Administration (USFDA), the reason for the recall of the bottles is...
- Germany’s Boehringer denied patent on HIV drugThe Indian Patent Office has denied Germany's Boehringer Ingelheim a patent on its key HIV drug, Nevirapine, for a version sold as Viramune...
- Government exempts AIDS drugs from customs dutyThe exemption will benefit Anti-Retroviral Drugs (ARV Drugs) -- Adult First Line, Adult Second Line and Paediatric Drugs.
- Exports to Europe from Ranbaxy's two plants to remain suspendedExports from Ranbaxy plants at Toansa and Dewas to Europe will remain suspended as probes are continuing, European health regulator EMA sai...
- EU, UK evaluating FDA findings on Ranbaxy's Toansa facilityDays after US FDA banned import of Ranbaxy products to America from its Toansa plant, health regulators of EU & UK have said they are evalu...
- Twelve stocks in focus in Friday morning tradeHere is a list of twelve stocks that are likely to be in action in morning trade today.
- Aurobindo Pharma gets USFDA nod for generic anti-HIV drugAurobindo Pharma today said it has received final approval from the US health regulator for its generic Nevirapine tablets and oral suspens...
- Now, US won't source AIDS drugs from RanbaxyUS government will not source drugs under its global AIDS drug supply programme from Ranbaxy plants in India. Top food myths| Successful bi...
- Ranbaxy drugs in US AIDS programme under scannerThe development follows the US Food and Drug Administration’s (USFDA) ban on Ranbaxy’s 30 generic drugs and seven APIs.
- German firm denied AIDS drug patentThe Delhi patent office has rejected German pharma major Boehringer Ingelheim’s product patent application for its paediatric form of the a...
- AIDS drug Viread prices may dip soonBlockbuster AIDS drug Viread is set to witness a price war in the domestic market in the next few days, benefitting lakhs of patients using...
- Ranbaxy gets approval to produce, sell anti-AIDS drugCountry's largest drug maker, Ranbaxy Laboratories Limited (RLL) on Monday said it had received approval to manufacture and market anti-AID...
- Aurobindo gets tentative USFDA nod for HIV-1 drugAurobindo Pharma on Monday said it has received a tentative New Drug Approval from USFDA for its fixed dose combination product used for tr...
Load More
